Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: December 1, 2016
This filing announces a strategic change in accounting principles. The Company will transition from U.S. Generally Accepted Accounting Principles (U.S. GAAP) to International Financial Reporting Standards (IFRS) effective January 1, 2017.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the current or prior periods. This document serves as a notification of an accounting standard change rather than a financial results report.
Material Changes
- Accounting Standards: The Company is changing its reporting framework from U.S. GAAP to IFRS.
- Effective Date: The new standards apply to financial reporting beginning January 1, 2017.
Guidance, Outlook, and Risks
Management Commentary: The filing includes an Investor News Release (Exhibit 99.1) and historical IFRS figures (Exhibit 99.2) to assist stakeholders in understanding the transition. No specific forward-looking guidance, risk factors, or contingencies regarding future performance are detailed in the text of this specific filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News Release) for detailed rationale behind the accounting change.
- Examine Exhibit 99.2 for historical IFRS figures to compare against prior U.S. GAAP reporting.
- Verify the impact of the IFRS transition on future financial statement comparability starting in 2017.